Higher Levels of Leflunomide Are Associated with Hemolysis and Are not Superior to Lower Levels for BK Virus Clearance in Renal Transplant Patients | American Society of Nephrology
Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis | Annals of the Rheumatic Diseases
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function | Arthritis Research & Therapy | Full Text
Frontiers | LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation
Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial - The Lancet Rheumatology
Leflunomide | C12H9F3N2O2 - PubChem
The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells | Leukemia
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis | Nature Communications
NF-κB activation as a pathological mechanism of septic shock and inflammation | American Journal of Physiology-Lung Cellular and Molecular Physiology
Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review - ScienceDirect
Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review - ScienceDirect
Leflunomide | C12H9F3N2O2 - PubChem
Individualization of leflunomide dosing in rheumatoid arthritis patients | Personalized Medicine
Inhibiting NF-κB activation by small molecules as a therapeutic strategy. - Abstract - Europe PMC
Individualization of leflunomide dosing in rheumatoid arthritis patients | Personalized Medicine
The role of Chinese herbal medicine in the management of adverse drug reactions of leflunomide in treating rheumatoid arthritis - ScienceDirect
Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis - Pharma Excipients
NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis - ScienceDirect
New Drugs for Rheumatoid Arthritis | NEJM
Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma | HTML
